Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with Factor VIII deficiency and a factor VIII inhibitor
Data up to Jan 2025
Total Citations Per Year
Abstract
References (35)
The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIII
1981 • 303 citations
Thrombosis or Myocardial Infarction in Congenital Clotting Factor Abnormalities and Chronic Thrombocytopenias
1983 • 189 citations
The use of factor eight inhibitor by-passing activity (FEIBA immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors
1983 • 182 citations
Recording the Size of Thyroid Nodules
1973 • 120 citations
Intravascular Coagulation with Use of Human Prothrombin Complex Concentrates
1976 • 91 citations
Thromboembolic Complications
1975 • 91 citations
The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleedings in patients with haemophilia A with an inhibitor to Factor VIII
1982 • 90 citations
Pathophysiology of Acute Myocardial Infarction, 1981
1981 • 86 citations
Postoperative Thromboses in Hemophilia B
1973 • 83 citations
Prothrombin Concentrates in Treatment of Christmas Disease and Allied Disorders
1969 • 57 citations
Myocardial Infarction After Factor IX Therapy
1981 • 55 citations
Infection and infarction. Acute viral (and other) infection in the onset, pathogenesis, and mimicry of acute myocardial infarction
1986 • 51 citations
Fatal Myocardial Infarction Following Therapy with Prothrombin Complex Concentrates in a Young Man with Hemophilia A
1984 • 50 citations
Hemophilia in the Child and Adult
1990 • 44 citations
Heparin for Common-Duct Stone (Cont.)
1973 • 43 citations
Acute myocardial infarction in a young hemophiliac patient during therapy with Factor IX concentrate and epsilon aminocaproic acid
1981 • 42 citations
Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor
1981 • 40 citations
Therapy with Factor IX Concentrate Resulting in DIC and Thromboembolic Phenomena
1978 • 33 citations
Use of Prothrombin Complex Concentrates in Hemophiliacs with Inhibitors: Clinical and Laboratory Studies
1978 • 32 citations
Vascular Lesions in Hemophilia B
1973 • 27 citations
Summary Report and Recommendations of the Task Force Members and Consultants
1975 • 26 citations
Angiographic evidence of hemorrhagic myocardial infarction after intracoronary thrombolysis with streptokinase
1983 • 24 citations
A Survey of the Effectiveness of Prothrombin Complex Concentrates in Controlling Hemorrhage in Patients with Hemophilia and Anti-Factor VIII Antibodies
1980 • 22 citations
Activated F IX Concentrate (FEIBA) Used in the Treatment of Haemophilic Patients with Antibody to F VIII
1978 • 21 citations
Hemophilia in the Child and Adult
1989 • 20 citations
Increased Fibrinopeptide A after Prothrombin Complex Concentrates
1980 • 18 citations
Treatment of inhibitor patients with activated prothrombin complex concentrates.
1984 • 18 citations
Early experience with the use of anti-inhibitor coagulant complex to treat bleeding in hemophiliacs with inhibitors to factor VIII.
1987 • 17 citations
Factor IX and thrombosis
1977 • 13 citations
Notfallbehandlung von Blutungskomplikationen bei Hemmkörper-Hämophilie mit aktivierten Prothrombinkomplex-Konzentraten
1977 • 11 citations
Coronary Artery Spasm, Coronary Artery Thrombosis, and Myocardial Infarction
1981 • 11 citations
Activated Prothrombin Complex Concentrates. Managing Hemophilia with Factor VIII Inhibitor.
1983 • 7 citations
Inhibitor treatment using unactivated prothrombin complex concentrates: the Pennsylvania experience--1978-1982.
1984 • 6 citations
Complications of Therapy in Hemophilia
1984 • 4 citations
Complications of therapy in hemophilia.
1984 • 3 citations